CellProthera and Alfresa Holdings have signed an MOU covering potential [...]

The FDA has approved Moderna’s mRNA seasonal influenza vaccine mFLUSIVA [...]

Vaderis Therapeutics has raised $152M and started a global Phase [...]

AC Immune has received FDA Fast Track designation and IND [...]

Calla Lily Clinical Care has been selected for Wellcome Leap’s [...]

Oncoinvent has published Phase 1 dosimetry data for Radspherin in [...]

The FDA has issued a Complete Response Letter for ITM-11, [...]

Grifols has completed patient follow-up in its Phase 3 SPARTA [...]

Almirall has entered a drug discovery collaboration with CrystalO to [...]

BioVie has reported topline results from a Phase 2 trial [...]